| Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles M Kumar, P Kulkarni, S Liu, N Chemuturi, DK Shah Advanced drug delivery reviews 194, 114708, 2023 | 94 | 2023 |
| Nanoparticles that do not compete with endogenous ligands–molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans D Zou, M Arora, R Ganugula, M Kumar, EM Scott, D Shah, MNVR Kumar Journal of Controlled Release 332, 64-73, 2021 | 7 | 2021 |
| Pharmacokinetics of AAV9 mediated trastuzumab expression in rat brain following systemic and local administration EA Chowdhury, M Ahuja, S Wu, S Liu, HW Huang, M Kumar, KS Sunkara, ... Journal of Pharmaceutical Sciences 113 (1), 131-140, 2024 | 4 | 2024 |
| Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling M Kumar, S Lanke, A Yadav, M Ette, DE Mager, DK Shah Antibodies 13 (3), 54, 2024 | | 2024 |
| Prescription Trend in Antihypertensive Drugs in Mumbai And Suburbs: A Survey GV Desai, NS Desai, DM D'souza, MS Kumar, MS Ningoo, RS Shah, ... Value in Health 19 (7), A872, 2016 | | 2016 |
Dr. Dhaval K. ShahProfessor, Department of Pharmaceutical Sciences, SUNY BuffaloDirección de correo verificada de buffalo.edu